VALT-T -0.8 MART-T -0.57 VIDY-T 0.04 RPRX-Q 0.35 NCSM-Q 1.61 HRTG-N 1.36 BA-N 6.14
Daily Stock Opinions and Ratings
Stockchase Opinions

Bruce Cooper Stressgen Biotechnologies Corp SSB-T TOP PICK Oct 16, 2000

Working on drug for treatment of Human Pathlonium virus
Bruce CooperBruce Cooper
Unknown
Unlock Rating
$7.000

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
Get Signals Create your Watchlist

You might be interested:

BUY

Stressgen Biotechnologies Corp(SSB-T)

May 12, 2003
They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.
Peter HodsonPeter Hodson
Unknown
Unlock Rating
$1.900

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY ON WEAKNESS

Stressgen Biotechnologies Corp(SSB-T)

May 14, 2003
A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.
Lou SchizasLou Schizas
Unknown
Unlock Rating
$1.780

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

Jun 30, 2003
On their watch list. Lost a lot of maney last year.
Benj GallanderBenj Gallander
No
Unlock Rating
$1.710

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Stressgen Biotechnologies Corp(SSB-T)

Oct 07, 2003
Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.
John Sinkins, CFAJohn Sinkins, CFA
No
Unlock Rating
$2.040

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

Dec 04, 2003
Have restructured and will need more money.
Peter HodsonPeter Hodson
No
Unlock Rating
$2.130

Stock price when the opinion was issued

biotechnology pharmaceutical
TRADE

Stressgen Biotechnologies Corp(SSB-T)

Dec 05, 2003
A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.
Benj GallanderBenj Gallander
No
Unlock Rating
$1.930

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

Stressgen Biotechnologies Corp(SSB-T)

Jun 15, 2004
Holds this stock personally. Risky could double.
Benj GallanderBenj Gallander
Owned
Unlock Rating
$1.060

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

Stressgen Biotechnologies Corp(SSB-T)

Nov 09, 2004
(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.
Benj GallanderBenj Gallander
No
Unlock Rating
$0.455

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

Nov 12, 2004
Trying to raise $50 million which is equivalent/more than their entire market cap.
Duncan StewartDuncan Stewart
No
Unlock Rating
$0.440

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

Jul 26, 2005
A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.
Peter HodsonPeter Hodson
No
Unlock Rating
$0.370

Stock price when the opinion was issued

biotechnology pharmaceutical

Build our watch list

Sign in to track investments
you care about

Latest Buy Signals

CMNY-T 0.01$50.09
HEQL-T 0.44$27
DXP-T 0.14$23.24
ZMMK-T 0.005$49.895
PYF-T 0.04$17.39

Today's Top Picks

VALT-T -0.8$40.6
MART-T -0.57$22.9
VIDY-T 0.04$35.23
RPRX-Q 0.35$33.1
NCSM-Q 1.61$32.71

Popular Articles

Latest Sell Signals

HPYT-T -0.105$9.175
RHT-X 0.005$0.215
GOOG-Q 2.95$155.75
GOOG-Q 2.95$155.75
T-T 0.03$20.8

Most Recent Experts

Daniel Straus

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

Stockchase Insights

5i Research

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica